Source: Arthritis & rheumatology. Unidade: FM
Subjects: NEFRITE, ENSAIO CLÍNICO, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACKAY, Meggan et al. Establishing surrogate kidney end points for lupus nephritis clinical trials: development and validation of a novel approach to predict future kidney outcomes. Arthritis & rheumatology, v. 71, n. 3, p. 411-419, 2019Tradução . . Disponível em: https://doi.org/10.1002/art.40724. Acesso em: 18 nov. 2024.APA
Mackay, M., Dall'era, M., Fishbein, J., Kalunian, K., Lesser, M., Sanchez-guerrero, J., et al. (2019). Establishing surrogate kidney end points for lupus nephritis clinical trials: development and validation of a novel approach to predict future kidney outcomes. Arthritis & rheumatology, 71( 3), 411-419. doi:10.1002/art.40724NLM
Mackay M, Dall'era M, Fishbein J, Kalunian K, Lesser M, Sanchez-guerrero J, Levy DM, Silverman E, Petri M, Arriens C, Borba Neto EF, Bonfá ESD de O. Establishing surrogate kidney end points for lupus nephritis clinical trials: development and validation of a novel approach to predict future kidney outcomes [Internet]. Arthritis & rheumatology. 2019 ; 71( 3): 411-419.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/art.40724Vancouver
Mackay M, Dall'era M, Fishbein J, Kalunian K, Lesser M, Sanchez-guerrero J, Levy DM, Silverman E, Petri M, Arriens C, Borba Neto EF, Bonfá ESD de O. Establishing surrogate kidney end points for lupus nephritis clinical trials: development and validation of a novel approach to predict future kidney outcomes [Internet]. Arthritis & rheumatology. 2019 ; 71( 3): 411-419.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/art.40724
